Fed Bioequivalence Study of CBZ Formulations

NCT02132897 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Bio-equivalence Study
Fed Conditions

Interventions

DRUG: Auration CR Tablets 400 Single Dose-Tegretol CR 400 Single Dose
DRUG: Tegretol CR 400 Single Dose-Auration CR 400 Single Dose

Sponsor

Center for Clinical Pharmacology Research Bdbeq S.A.